SIERRA ONCOLOGY, INC. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ddcf303e-96ad-4a68-83e4-a249857fa677/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-94.7M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-009473 |
| FY 2020 | $-80.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012234 |
| FY 2019 | $-88.3M | 2019-01-01 – 2019-12-31 | evidence 0001193125-20-059703 |
| FY 2018 | $-53.3M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-055556 |
| FY 2017 | $-42.0M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-059374 |
| FY 2016 | $-47.9M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-066582 |
| FY 2015 | $-53.3M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-490742 |
| FY 2014 | $-23.9M | 2014-01-01 – 2014-12-31 | evidence 0001193125-16-490742 |
| FY 2013 | $-6.8M | 2013-01-01 – 2013-12-31 | evidence 0001193125-16-490742 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).